Purpose: Electronic portal imaging devices (EPIDs) could potentially be useful for either in-vivo or pre-treatment dosimetric verification of external beam radiation therapy. The accuracy of EPID for dosimetric purposes is highly dependent on the specific method used for the determination of dose-response characteristics. The aim of this study was to develop a simple and time-saving EPID back-projection dosimetry algorithm for 2D dose verification in 3D conformal and intensity-modulated beams.
Methods: The procedure of dose reconstruction includes a first calibration step using ionization chamber measurements to convert the Electronic Portal Image (EPI) pixel values into an absorbed dose in water. Subsequently, several corrections were applied to the Portal Dose Images (PDIs) for the effect of field size, attenuator thickness, scattering radiation, beam hardening and EPID off-axis response. Furthermore, to consider tissue inhomogeneity for accurate dose reconstruction, the patient's water equivalent path length (WEPL) was calculated using a range of digitally reconstructed radiographs (DRRs) obtained at various thicknesses by Plastimatch software. The EPID-derived dose maps accuracy was assessed by comparing with the treatment planning system (TPS) calculated dose in the prostate region of Alderson phantom irradiated with 3D conformal and intensity-modulated beams.
Results: The gamma analysis for the dose plane showed agreements of 96.95% and 93.5% for 3D conformal and IMRT fields, respectively, with 3%/3 mm acceptance criteria.
Conclusion: The presented algorithm can provide accurate absolute 2D dose maps for clinical use in the context of 3DCRT or IMRT Quality Assurance (QA) programs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.apradiso.2022.110116 | DOI Listing |
JAMA
January 2025
CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy.
Importance: Essential thrombocythemia, a clonal myeloproliferative neoplasm with excessive platelet production, is associated with an increased risk of thrombosis and bleeding. The annual incidence rate of essential thrombocythemia in the US is 1.5/100 000 persons.
View Article and Find Full Text PDFCurr Rheumatol Rep
January 2025
Rheumatologisches Versorgungszentrum Steglitz, Ruhr Universität Bochum, Schloßstr.110, 12163, Berlin, Germany.
Purpose Of Review: Axial spondyloarthritis (axSpA) is a rather prevalent chronic inflammatory rheumatic disease that affects already relatively young patients. It has been known better since the end of the nineteenth century but quite a lot has been learned since the early 60ies when the first classification (diagnostic) criteria for ankylosing spondylitis (AS) were agreed on. I have been part of many developments in the last 30 years, and I'm happy to have been able to contribute to the scientific progress in terms of diagnosis, imaging, pathophysiology and therapy.
View Article and Find Full Text PDFMar Biotechnol (NY)
January 2025
Department of Aquatic Life Medicine, Pukyong National University, Busan, 48513, South Korea.
Vibriosis caused by Vibrio anguillarum has been an important bacterial disease in cultured rainbow trout (Oncorhynchus mykiss). In the present study, we evaluated the protective efficacy of a vaccine that consists of formalin-killed (FK) V. anguillarum and the alr genes knockout auxotrophic-live (AL) V.
View Article and Find Full Text PDFNaunyn Schmiedebergs Arch Pharmacol
January 2025
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
Herbicides such as paraquat (PQ) are frequently utilized particularly in developing nations. The present research concentrated on the pulmonary lesions triggered by PQ and the beneficial effect of the angiotensin receptor neprilysin inhibitor (ARNI), sacubitril/valsartan, against such pulmonary damage. Five groups of rats were established: control, ARNI, PQ (10 mg/kg), ARNI 68 + PQ, and ARNI 34 + PQ.
View Article and Find Full Text PDFPulm Ther
January 2025
US Medical Affairs, GSK, ATC Fowler Building, 410 Blackwell Street, Durham, NC, 27701, USA.
Introduction: Escalation to single- or multiple-inhaler triple therapy (SITT; MITT) is a recommended option for patients with asthma who remain uncontrolled by medium-dose inhaled corticosteroid/long-acting β-agonist; however, characterization of elderly users of triple therapy is limited. This real-world cohort study describes demographics and clinical characteristics of elderly patients with asthma with and without comorbid chronic obstructive pulmonary disease (COPD) who are new users of triple therapy, and asthma treatment patterns preceding triple therapy initiation.
Methods: This retrospective cohort study used administrative claims data from the Optum Clinformatics Data Mart database.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!